553 related articles for article (PubMed ID: 23794360)
1. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2013 Sep; 69(3):633-51. PubMed ID: 23794360
[TBL] [Abstract][Full Text] [Related]
2. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
Abeywardena MY; Patten GS
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
[TBL] [Abstract][Full Text] [Related]
3. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.
Dasilva G; Medina I
Free Radic Biol Med; 2019 Nov; 144():90-109. PubMed ID: 30902758
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update.
Albracht-Schulte K; Kalupahana NS; Ramalingam L; Wang S; Rahman SM; Robert-McComb J; Moustaid-Moussa N
J Nutr Biochem; 2018 Aug; 58():1-16. PubMed ID: 29621669
[TBL] [Abstract][Full Text] [Related]
5. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
Nettleton JA; Katz R
J Am Diet Assoc; 2005 Mar; 105(3):428-40. PubMed ID: 15746832
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial.
Phelan N; O'Connor A; Kyaw Tun T; Correia N; Boran G; Roche HM; Gibney J
Am J Clin Nutr; 2011 Mar; 93(3):652-62. PubMed ID: 21270384
[TBL] [Abstract][Full Text] [Related]
7. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
9. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
10. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
Russo GL
Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
[TBL] [Abstract][Full Text] [Related]
11. Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in Male Obesity Secondary Hypogonadism Syndrome.
Noce A; Marrone G; Di Daniele F; Di Lauro M; Pietroboni Zaitseva A; Wilson Jones G; De Lorenzo A; Di Daniele N
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825328
[TBL] [Abstract][Full Text] [Related]
12. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
Delarue J; LeFoll C; Corporeau C; Lucas D
Reprod Nutr Dev; 2004; 44(3):289-99. PubMed ID: 15460168
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.
Martínez-Fernández L; Laiglesia LM; Huerta AE; Martínez JA; Moreno-Aliaga MJ
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):24-41. PubMed ID: 26219838
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence.
Weylandt KH; Serini S; Chen YQ; Su HM; Lim K; Cittadini A; Calviello G
Biomed Res Int; 2015; 2015():143109. PubMed ID: 26301240
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
17. Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study.
Mashavave G; Kuona P; Tinago W; Stray-Pedersen B; Munjoma M; Musarurwa C
BMC Clin Pathol; 2016; 16():14. PubMed ID: 27499701
[TBL] [Abstract][Full Text] [Related]
18. Obesity-Associated Dyslipidemia Is Moderated by Habitual Intake of Marine-Derived n-3 Polyunsaturated Fatty Acids in Yup'ik Alaska Native People: A Cross-Sectional Mediation-Moderation Analysis.
Boyer BB; Wiener HW; Hopkins SE; Purnell JQ; O'Brien DM; Aliwarga T; Pomeroy JJ; Aslan JE; Thummel KE; Tiwari HK
J Nutr; 2023 Jan; 153(1):279-292. PubMed ID: 36913463
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
Flachs P; Rossmeisl M; Bryhn M; Kopecky J
Clin Sci (Lond); 2009 Jan; 116(1):1-16. PubMed ID: 19037880
[TBL] [Abstract][Full Text] [Related]
20. Dietary n-3 polyunsaturated fatty acids modify fatty acid composition in hepatic and abdominal adipose tissue of sucrose-induced obese rats.
Alexander-Aguilera A; Berruezo S; Hernández-Diaz G; Angulo O; Oliart-Ros R
J Physiol Biochem; 2011 Dec; 67(4):595-604. PubMed ID: 21695545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
